Clinical Trials in Florida

Showing 3941-3960 of 12,796 trials

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

NCT05466890

The purpose of this study is to compare PL8177 (a melanocortin receptor agonist) to placebo (in a 3:1 ratio-meaning that for every 3 people that get the active drug, one will receive placebo). The study treatment will be for 8 weeks. The study will measure safety and the body's ability to handle PL8177 and look at the improvement and healing of the intestine after 8 weeks of treatment. The study will include adult males and nonpregnant, nonlactating females with acute Ulcerative Colitis (UC).

Ulcerative ColitisUlcerative Colitis AcuteUlcerative+1 more

Palatin Technologies, Inc16 participantsStarted Sep 2022

Tucson, Arizona, United States • Lancaster, California, United States • Tarzana, California, United States +11 more locations

COMPLETEDPhase 1/249 miles

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

NCT01922050

Part 1: To identify Maximum Tolerated Dose (MTD) levels of two formulations of LEO 43204 after once daily treatment for two consecutive days Part 2: To evaluate efficacy of two formulations of LEO 43204 in two doses after once daily treatment for two consecutive days compared to vehicle formulations

Actinic Keratosis

LEO Pharma320 participantsStarted Oct 2013

Phoenix, Arizona, United States • Lomita, California, United States • San Diego, California, United States +22 more locations

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Find Trials by Condition in Florida

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

Information Visualizations to Enhance HIV-related Communication